Two novel preanalysis sample treatment tools were evaluated in combination with four DNA extraction kits for the selective isolation of bacterial DNA from whole blood. The combination of performing a preanalysis sample treatment and using a larger sample volume increased the detection limit to 50 CFU per ml.
plate DNA. Optimal thermal-cycling conditions were as follows: initial denaturation at 95°C for 15 min, 42 cycles of denaturation for 15 s at 95°C, and annealing at 60°C for 1 min.
The detection limit of all DNA extraction procedures was determined and is presented in Table 1 . Two conventional DNA extraction kits (QIAamp and MPLC) were tested with and without two different preanalysis sample treatment protocols. Preanalysis sample treatment, with either MolYsis Basic or Looxster, combined with QIAamp extraction, based on a spin-column format, did not result in an increase in detection limit. Both procedures performed equally and were able to detect three target genes at a minimal concentration of 10 3 CFU per ml, which was analogous to 16 CFU per PCR. Recently, a study by Horz et al. investigated if MolYsis Basic could indeed eliminate human DNA in oral samples to improve the detection of bacterial DNA (4) . They found that the use of MolYsis Basic prior to DNA isolation reduced the level of human DNA. However, this effect was accompanied with a partial loss of bacterial DNA. The MPLC kit performed the same as the QIAamp kit, i.e., a detection limit of 10 3 CFU per ml. The MPLC kit in combination with MolYsis Basic could detect 500 CFU per ml. However, when combined with Looxster, the minimal detectable amount of bacteria was 10 4 CFU per ml (data not shown). This was most likely due to the incompatibility of the Looxster kit and the MPLC elution buffer, which is essential to the performance of the MPLC kit.
The MagSi-DNA kit and the MolYsis Complete kit represented two novel procedures for the targeted isolation of bacterial DNA ( Table 1 ). The MagSi-DNA kit, a novel combination of two sample preparation methods, showed results similar to the results obtained after conventional DNA extraction. The minimal detectable amount of bacteria was 10 3 CFU per ml. MolYsis Complete was able to achieve bacterial detection at a concentration of 50 CFU per ml and therefore achieved the lowest detection limit compared to those of all the other DNA extraction methods. In this case, the detection of 50 CFU per ml was analogous to 4 CFU per PCR. MolYsis Complete provides a combination of preanalysis sample treatment and targeted DNA extraction containing all the buffers and reagents necessary for human DNA removal, bacteria enrichment, and bacterial DNA extraction. These findings suggest that the combination of two complementary matching sample preparation procedures and the use of a larger volume of blood sample both contributed to a higher level of bacterial detection. Few studies in the past have focused on pathogen detection in whole-blood samples; instead, experiments were performed using bacterial suspensions or clinical sample materials, such as pleural fluid, pus, synovial fluid, and pericardial fluid (5, 8) . Zucol et al. evaluated different DNA extraction protocols for whole-blood samples, followed by broad-range, real-time PCR, targeting the 16S rRNA gene in Staphylococcus aureus and Escherichia coli. They achieved the detection of bacterial concentrations of Ͼ10 CFU per PCR, which was analogous to 10 3 CFU per ml (11) . Automation, ease of use, duration, and costs of the procedure are each important factors also contributing to the extent of the implementation in diagnostic laboratories. Table 2 shows the detection limit, the duration in time, and the cost per sample obtained for the different DNA isolation protocols. Except for the MPLC kit, which is performed on the automated MagNA Pure instrument, all procedures are performed manually. The extraction methods were all considered easy to perform. The hands-on time for the manual DNA isolation methods combined with sample pretreatment varied between 120 and 240 min.
In conclusion, we investigated whether the addition of a a Detection represented by a threshold cycle value of Ͻ40 is indicated by a ϩ; no detection is indicated by a Ϫ. Detection was determined for the three gene targets mecA, femA, and sa442. The data represent results from three independent replicate experiments. ND, not determined.
b MolYsis Basic is a preanalysis sample treatment for the removal of human DNA and bacterial enrichment in whole-blood samples. c Looxster is a preanalysis sample treatment for the enrichment of bacterial DNA from total DNA.
preanalysis sample treatment could improve the efficiency of purifying bacterial DNA from whole-blood samples. The combination of performing a preanalysis sample treatment and using a larger sample volume achieved the detection of only 50 CFU per ml of whole blood (Ͻ5 CFU per reaction), emphasizing that the rate of efficiency was attributed to more than one factor. These results confirmed that the efficiency of DNA extraction, especially for clinical samples such as whole blood, is a crucial element in the process of molecular pathogen detection. Ultimately, a combination of optimal sample processing and molecular detection techniques will lead to rapid and accurate pathogen detection for the diagnosis of bloodstream infections. 
